Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy: a cost-utility analysis from the perspective of Chinese healthcare system

Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy: a cost-utility analysis from the perspective of Chinese healthcare system

BackgroundTenecteplase improves functional outcomes in acute ischemic stroke (AIS) patients treated 4.5 to 24 h after symptom onset who do not undergo thrombectomy. However, its cost-utility remains unexamined.MethodsA hybrid model combining a short-term decision tree and a long-term Markov model wa...

Full description

Bibliographic Details
Main Authors: Maolin Chen, Ying Yu, Baozhong Yu, Yudan Cao, Yake Lou, Yudong Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Neurology
Subjects:
cost-utility analysis
economic evaluation
tenecteplase
stroke
thrombectomy
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1551332/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1551332/full

Similar Items